14:30-15:30 • Saturday, 4th October 2014

Future technologies for the improvement
of clotting factor pharmacokinetics

Sponsored Satellite SymposiumChairman and Co-Chair

Stephen James, PhD, Vice President Head of Drug Design & Development Sobi, Stockholm, Sweden	Stefan Lethagen, MD, PhD Professor/ Vice President Medical and Clinical Sciences Haemophilia Sobi, Stockholm, Sweden

 

	Welcome and Introduction Stephen James
	Novel recombinant approaches to modulate pharmacokinetics of biologicals Stefan Svensson Gelius, PhD Principal Scientist, Drug Design & Development, Sobi, Stockholm, Sweden
	Application of XTEN and other recombinant fusions to enhance clotting factors John Kulman, PhD Principal Scientist, Hematology Research Biogen Idec, Cambridge, USA
	Panel discussion Stefan Lethagen
	Closing of the meeting Stefan Lethagen

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Download SOBI’s invitation here